The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $24.58

Today's change+0.28 +1.15%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $24.58

Today's change+0.28 +1.15%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

Sabra Health Care REIT Inc Hits New 20-day High

Sabra Health Care REIT Inc closed up Friday by (U.S.)$0.28 or 1.15% to (U.S.)$24.58 and setting a new 20-day high. Over the last five days, shares have gained 9.88% and 21.50% year to date. Shares have outperformed the S&P 500 by 14.11% during the last year.

Key company metrics

  • Open(U.S.) $24.41
  • Previous close(U.S.) $24.30
  • High(U.S.) $24.70
  • Low(U.S.) $24.08
  • Bid / Ask(U.S.) $22.40 / (U.S.) $24.69
  • YTD % change+21.50%
  • Volume820,814
  • Average volume (10-day)513,218
  • Average volume (1-month)587,793
  • Average volume (3-month)498,214
  • 52-week range(U.S.) $14.92 to (U.S.) $26.40
  • Beta1.22
  • Trailing P/E26.03×
  • P/E 1 year forward26.49×
  • Forward PEG10.81×
  • Indicated annual dividend(U.S.) $1.68
  • Dividend yield6.83%
  • Trailing EPS(U.S.) $0.94
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue62746367
Total other revenue--------
Total revenue62746367
Gross profit61736164
Total cost of revenue1113
Total operating expense41397446
Selling / general / administrative7579
Research & development--------
Depreciation / amortization17161818
Interest expense (income), net operating16161716
Unusual expense (income)00300
Other operating expenses, total--------
Operating income2135-1121
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets10-52
Other--------
Income before tax2537-1625
Income after tax2537-1625
Income tax, total--------
Net income2537-1625
Total adjustments to net income-3-3-3-3
Net income before extra. items2537-1625
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2335-1823
Inc. avail. to common incl. extra. items2335-1823
Diluted net income2335-1823
Dilution adjustment--------
Diluted weighted average shares66666565
Diluted EPS excluding extraordinary itemsvalue per share0.350.53-0.280.34
Dividends per sharevalue per share0.420.420.410.41
Diluted normalized EPSvalue per share0.330.530.260.31